Status:
COMPLETED
Milligan-Morgan Versus Dearterialization With Mucopexy
Lead Sponsor:
Università degli Studi dell'Aquila
Conditions:
Hemorrhoids
Hemorrhoid Prolapse
Eligibility:
All Genders
18-80 years
Brief Summary
Nowadays, there are several methods that can be used for grade III hemorrhoidal disease, according to Goligher classificiation. Milligan Morgan hemorrhoidectomy is considered the most effective treatm...
Detailed Description
The study will be of a multicentre observational retrospective type. Any Italian Center belonging to the Italian Society of Colorectal Surgery (SICCR) in which at least 30 procedures are performed per...
Eligibility Criteria
Inclusion
- ≥18 years-old
- Goligher's grade III haemorrhoidal disease
- indication to elective Doppler-guided or non-Doppler guided HAL surgery associated with mucopexy or Milligan-Morgan hemorrhoidectomy.
Exclusion
- Recurrent disease
- bleeding disorders
- chronic inflammatory bowel diseases
- vasculopathies
- combined surgical techniques (HAL with mucopexy and removal of one or more haemorrhoidal nodules)
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 25 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04863963
Start Date
July 1 2021
End Date
September 25 2021
Last Update
September 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antonio Giuliani
L’Aquila, AQ, Italy, 67100